These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2187809)

  • 1. Containment as a mechanism of nonspecific enhancement of defenses against bacterial infection.
    Polk HC; Lamont PM; Galland RB
    Infect Immun; 1990 Jun; 58(6):1807-11. PubMed ID: 2187809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonspecific enhancement of resistance to local bacterial infection in starved mice.
    Galland RB; Trachtenberg LS; Rynerson N; Polk HC
    Arch Surg; 1982 Feb; 117(2):161-4. PubMed ID: 7034676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration by muramyl dipeptide of the effect of induced hyperferremia upon Klebsiella infection in mice.
    Brewer RJ; Galland RB; Polk HC
    Infect Immun; 1982 Oct; 38(1):175-8. PubMed ID: 6754611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The enhancement of host defenses against infection--search for the Holy Grail?
    Polk HC
    Surgery; 1986 Jan; 99(1):1-6. PubMed ID: 3941994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muramyl dipeptide increases tolerance to shock and bacterial challenge in mice.
    Ausobsky JR; Cheadle WG; Brosky BG; Polk HC
    Br J Surg; 1984 Feb; 71(2):151-3. PubMed ID: 6362769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonspecific enhancement of host defenses against infection: experimental evidence of a new order of efficacy and safety.
    Polk HC; Calhoun JH; Lowrey LD; Blanchard SP; Brewer RJ; Adams ST; Chedid L
    Surgery; 1981 Aug; 90(2):376-80. PubMed ID: 7020139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-specific stimulation of host defenses against a bacterial challenge in malnourished hosts.
    Galland RB; Polk HC
    Br J Surg; 1982 Nov; 69(11):665-8. PubMed ID: 6751460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of copovithane as a nonspecific immunomodulator in surgically simulated sepsis.
    Hershman MJ; Trachtenberg LS; Pietsch JD; Mooney TH; DeWeese RC; Cheadle WG
    J Invest Surg; 1989; 2(4):423-9. PubMed ID: 2488006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of muramyl dipeptide in the therapy of established experimental bacterial infection.
    Ausobsky JR; Scuitto M; Trachtenberg LS; Polk HC
    Br J Exp Pathol; 1984 Feb; 65(1):1-9. PubMed ID: 6365142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Klebsiella pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl tripeptide phosphatidylethanolamide.
    Melissen PM; van Vianen W; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 1994 Jan; 38(1):147-50. PubMed ID: 8141571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonspecific stimulation of host defenses against bacterial challenge in immunosuppressed mice.
    Galland RB; Heine KJ; Polk HC
    Arch Surg; 1983 Mar; 118(3):333-7. PubMed ID: 6824433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of host resistance to microbial infections by recombinant human interleukin-1 alpha.
    Minami A; Fujimoto K; Ozaki Y; Nakamura S
    Infect Immun; 1988 Dec; 56(12):3116-20. PubMed ID: 3263325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the local inflammatory response to bacterial infection by muramyl dipeptide.
    Lamont PM; Schrodt GR; Galland RB; Kaufman CM; Cheadle WG; Polk HC
    Br J Exp Pathol; 1984 Jun; 65(3):319-25. PubMed ID: 6743532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of nonspecific antimicrobial resistance of mice to Klebsiella pneumoniae septicemia by liposome-encapsulated muramyl tripeptide phosphatidylethanolamine and interferon-gamma alone or combined.
    ten Hagen TL; van Vianen W; Bakker-Woudenberg IA
    J Infect Dis; 1995 Feb; 171(2):385-92. PubMed ID: 7844375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant.
    Parant M; Parant F; Chedid L
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3395-9. PubMed ID: 356054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections.
    Osada Y; Mitsuyama M; Une T; Matsumoto K; Otani T; Satoh M; Ogawa H; Nomoto K
    Infect Immun; 1982 Jul; 37(1):292-300. PubMed ID: 6809630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulatory effects of muramyl dipeptide upon neutrophils isolated from a local bacterial infection.
    Lamont PM; Maier KG; Melton L; Polk HC
    Br J Exp Pathol; 1987 Oct; 68(5):655-61. PubMed ID: 3318904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muramyl dipeptide enhances survival from experimental peritonitis.
    Brown GL; Foshee H; Pietsch J; Polk HC
    Arch Surg; 1986 Jan; 121(1):47-9. PubMed ID: 3942499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-infectious activity of liposomal muramyl dipeptides in immunodeficient CBA/N mice.
    Phillips NC; Chedid L
    Infect Immun; 1987 Jun; 55(6):1426-30. PubMed ID: 3553001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity.
    Chedid LA; Parant MA; Audibert FM; Riveau GJ; Parant FJ; Lederer E; Choay JP; Lefrancier PL
    Infect Immun; 1982 Feb; 35(2):417-24. PubMed ID: 7035362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.